Wealth Enhancement Advisory Services LLC Boosts Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Wealth Enhancement Advisory Services LLC raised its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 4.4% during the 1st quarter, Holdings Channel.com reports. The firm owned 7,519 shares of the biotechnology company’s stock after buying an additional 319 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Axon Enterprise were worth $2,353,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AXON. Ameriprise Financial Inc. grew its stake in Axon Enterprise by 10.1% in the third quarter. Ameriprise Financial Inc. now owns 379,286 shares of the biotechnology company’s stock valued at $75,474,000 after purchasing an additional 34,728 shares during the last quarter. Sei Investments Co. grew its stake in shares of Axon Enterprise by 2.2% during the third quarter. Sei Investments Co. now owns 113,730 shares of the biotechnology company’s stock worth $22,631,000 after acquiring an additional 2,443 shares during the last quarter. TimesSquare Capital Management LLC grew its stake in shares of Axon Enterprise by 52.0% during the third quarter. TimesSquare Capital Management LLC now owns 43,000 shares of the biotechnology company’s stock worth $8,557,000 after acquiring an additional 14,710 shares during the last quarter. Comerica Bank grew its stake in shares of Axon Enterprise by 2,079.4% during the third quarter. Comerica Bank now owns 141,750 shares of the biotechnology company’s stock worth $28,207,000 after acquiring an additional 135,246 shares during the last quarter. Finally, Polar Capital Holdings Plc grew its stake in shares of Axon Enterprise by 292.0% during the third quarter. Polar Capital Holdings Plc now owns 265,464 shares of the biotechnology company’s stock worth $52,825,000 after acquiring an additional 197,746 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on AXON. Argus began coverage on Axon Enterprise in a research note on Wednesday, March 13th. They set a “buy” rating and a $380.00 price target on the stock. StockNews.com lowered Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. JMP Securities reaffirmed a “market outperform” rating and set a $375.00 target price on shares of Axon Enterprise in a report on Tuesday, May 7th. JPMorgan Chase & Co. lifted their target price on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. Finally, Morgan Stanley boosted their price target on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, April 26th. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $335.27.

Insider Activity

In related news, Director Jeri Williams sold 308 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total transaction of $95,501.56. Following the completion of the sale, the director now owns 1,607 shares in the company, valued at $498,282.49. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other Axon Enterprise news, insider Jeffrey C. Kunins sold 43,668 shares of Axon Enterprise stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.94, for a total transaction of $13,534,459.92. Following the transaction, the insider now owns 189,719 shares of the company’s stock, valued at $58,801,506.86. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Jeri Williams sold 308 shares of Axon Enterprise stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the transaction, the director now directly owns 1,607 shares in the company, valued at approximately $498,282.49. The disclosure for this sale can be found here. In the last quarter, insiders sold 89,447 shares of company stock worth $27,684,677. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Stock Up 1.2 %

Shares of NASDAQ:AXON opened at $296.56 on Friday. The stock has a market cap of $22.38 billion, a P/E ratio of 86.71 and a beta of 0.95. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. Axon Enterprise, Inc. has a 52-week low of $175.37 and a 52-week high of $329.87. The business has a fifty day moving average of $294.68 and a two-hundred day moving average of $285.92.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.20. The firm had revenue of $460.74 million for the quarter, compared to analyst estimates of $441.57 million. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. Axon Enterprise’s revenue was up 34.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.51 EPS. On average, research analysts expect that Axon Enterprise, Inc. will post 2.35 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.